The International Association for the Study of Lung Cancer
The IASLC is a global multidisciplinary organization dedicated to eradication of all forms of lung cancer. From provision of educational events around the world and virtually to research projects and publications that advance the science of lung cancer, the IASLC's members—consisting of medical, surgical, and radiation oncologists, as well as other thoracic oncology specialists such as nurses, basic scientists, pathologists, radiologists, pulmonologists, statisticians, patient research advocates, patients, and their caregivers—are raising the bar for care of patients with lung cancer.
In Focus
Kristin Richeimer, CAE, DES named IASLC Interim Chief Executive Officer
The Board of Directors of the International Association for the Study of Lung Cancer (IASLC) is pleased to announce the appointment of Kristin Richeimer, CAE, DES to the position of Interim Chief Executive Officer, effective immediately.
IASLC Language Guide
In line with the IASLC Equity Statement and in step with the ASCO Language of Respect, we are proud to announce the release of the IASLC Language Guide. The guide was established to instill best practices with commonly used phrases related to patient care. The IASLC will be folding the language found in the guide into all aspects of thoracic oncology education, from abstracts to faculty guidelines to podium presentations.
Our Impact
8,000+ members from over 100 countries, all united by a single goal: to conquer thoracic cancers worldwide.
Our Impact
8,000+ members from over 100 countries, all united by a single goal: to conquer thoracic cancers worldwide.
Latest News
Our Work
In Numbers
8,000+ members from over 100 countries, all united by a single goal: to conquer thoracic cancers worldwide.
Upcoming Meetings & Webinars
Journal of Thoracic Oncology & JTO Clinical and Research Reports
Lung and thoracic specialists count on the IASLC’s journals to provide perspective on innovation in prevention, detention, diagnosis and cutting-edge treatments. As a leading medical journal, JTO focuses on lung and thoracic cancers and is dedicated to presenting original research reviews and opinions from a wide range of disciplines within the medical community. JTO CRR, the official open access journal of the IASLC, complements the JTO by offering authors a gold open access publication option.